273 related articles for article (PubMed ID: 16159227)
1. Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnology.
Khaled A; Guo S; Li F; Guo P
Nano Lett; 2005 Sep; 5(9):1797-808. PubMed ID: 16159227
[TBL] [Abstract][Full Text] [Related]
2. RNA nanotechnology: engineering, assembly and applications in detection, gene delivery and therapy.
Guo P
J Nanosci Nanotechnol; 2005 Dec; 5(12):1964-82. PubMed ID: 16430131
[TBL] [Abstract][Full Text] [Related]
3. Construction of folate-conjugated pRNA of bacteriophage phi29 DNA packaging motor for delivery of chimeric siRNA to nasopharyngeal carcinoma cells.
Guo S; Huang F; Guo P
Gene Ther; 2006 May; 13(10):814-20. PubMed ID: 16482206
[TBL] [Abstract][Full Text] [Related]
4. Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA.
Guo S; Tschammer N; Mohammed S; Guo P
Hum Gene Ther; 2005 Sep; 16(9):1097-109. PubMed ID: 16149908
[TBL] [Abstract][Full Text] [Related]
5. Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.
Shu Y; Haque F; Shu D; Li W; Zhu Z; Kotb M; Lyubchenko Y; Guo P
RNA; 2013 Jun; 19(6):767-77. PubMed ID: 23604636
[TBL] [Abstract][Full Text] [Related]
6. Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.
Shu D; Li H; Shu Y; Xiong G; Carson WE; Haque F; Xu R; Guo P
ACS Nano; 2015 Oct; 9(10):9731-40. PubMed ID: 26387848
[TBL] [Abstract][Full Text] [Related]
7. Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.
Xu C; Haque F; Jasinski DL; Binzel DW; Shu D; Guo P
Cancer Lett; 2018 Feb; 414():57-70. PubMed ID: 28987384
[TBL] [Abstract][Full Text] [Related]
8. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex.
Lee MY; Park SJ; Park K; Kim KS; Lee H; Hahn SK
ACS Nano; 2011 Aug; 5(8):6138-47. PubMed ID: 21739990
[TBL] [Abstract][Full Text] [Related]
9. Engineering RNA-protein complexes with different shapes for imaging and therapeutic applications.
Osada E; Suzuki Y; Hidaka K; Ohno H; Sugiyama H; Endo M; Saito H
ACS Nano; 2014 Aug; 8(8):8130-40. PubMed ID: 25058166
[TBL] [Abstract][Full Text] [Related]
10. Controlling RNA self-assembly to form filaments.
Nasalean L; Baudrey S; Leontis NB; Jaeger L
Nucleic Acids Res; 2006; 34(5):1381-92. PubMed ID: 16522648
[TBL] [Abstract][Full Text] [Related]
11. Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology.
Binzel DW; Shu Y; Li H; Sun M; Zhang Q; Shu D; Guo B; Guo P
Mol Ther; 2016 Aug; 24(7):1267-77. PubMed ID: 27125502
[TBL] [Abstract][Full Text] [Related]
12. Methods for assembling B-cell lymphoma specific and internalizing aptamer-siRNA nanoparticles via the sticky bridge.
Zhou J; Rossi JJ; Shum KT
Methods Mol Biol; 2015; 1297():169-85. PubMed ID: 25896003
[TBL] [Abstract][Full Text] [Related]
13. Assembly of therapeutic pRNA-siRNA nanoparticles using bipartite approach.
Shu Y; Cinier M; Fox SR; Ben-Johnathan N; Guo P
Mol Ther; 2011 Jul; 19(7):1304-11. PubMed ID: 21468002
[TBL] [Abstract][Full Text] [Related]
14. Functional assays for specific targeting and delivery of RNA nanoparticles to brain tumor.
Lee TJ; Haque F; Vieweger M; Yoo JY; Kaur B; Guo P; Croce CM
Methods Mol Biol; 2015; 1297():137-52. PubMed ID: 25896001
[TBL] [Abstract][Full Text] [Related]
15. RNA self-assembly and RNA nanotechnology.
Grabow WW; Jaeger L
Acc Chem Res; 2014 Jun; 47(6):1871-80. PubMed ID: 24856178
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional polyamidoamine-modified selenium nanoparticles dual-delivering siRNA and cisplatin to A549/DDP cells for reversal multidrug resistance.
Zheng W; Cao C; Liu Y; Yu Q; Zheng C; Sun D; Ren X; Liu J
Acta Biomater; 2015 Jan; 11():368-80. PubMed ID: 25204523
[TBL] [Abstract][Full Text] [Related]
17. Specific delivery of delta-5-desaturase siRNA via RNA nanoparticles supplemented with dihomo-γ-linolenic acid for colon cancer suppression.
Xu Y; Pang L; Wang H; Xu C; Shah H; Guo P; Shu D; Qian SY
Redox Biol; 2019 Feb; 21():101085. PubMed ID: 30584980
[TBL] [Abstract][Full Text] [Related]
18. Design Strategy to Access siRNA-Encapsulating DNA "Nanosuitcases" That Can Conditionally Release Their Cargo.
Bujold KE; Fakih HH; Sleiman HF
Methods Mol Biol; 2019; 1974():69-81. PubMed ID: 31098996
[TBL] [Abstract][Full Text] [Related]
19. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
[TBL] [Abstract][Full Text] [Related]
20. Versatile RNA tetra-U helix linking motif as a toolkit for nucleic acid nanotechnology.
Bui MN; Brittany Johnson M; Viard M; Satterwhite E; Martins AN; Li Z; Marriott I; Afonin KA; Khisamutdinov EF
Nanomedicine; 2017 Apr; 13(3):1137-1146. PubMed ID: 28064006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
